nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Abiraterone—prostate cancer	0.174	0.338	CbGbCtD
Zoledronate—ABCC1—Conjugated Estrogens—prostate cancer	0.0824	0.16	CbGbCtD
Zoledronate—ABCC1—Mitoxantrone—prostate cancer	0.0749	0.145	CbGbCtD
Zoledronate—ABCC1—Epirubicin—prostate cancer	0.0607	0.118	CbGbCtD
Zoledronate—ABCC1—Etoposide—prostate cancer	0.0473	0.0918	CbGbCtD
Zoledronate—ABCC1—Docetaxel—prostate cancer	0.0432	0.0839	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—prostate cancer	0.0322	0.0626	CbGbCtD
Zoledronate—GGPS1—prostate gland—prostate cancer	0.0071	0.101	CbGeAlD
Zoledronate—GGPS1—seminal vesicle—prostate cancer	0.00601	0.0853	CbGeAlD
Zoledronate—GGPS1—renal system—prostate cancer	0.00484	0.0687	CbGeAlD
Zoledronate—GGPS1—urethra—prostate cancer	0.00475	0.0675	CbGeAlD
Zoledronate—CA14—prostate gland—prostate cancer	0.00424	0.0603	CbGeAlD
Zoledronate—GGPS1—bone marrow—prostate cancer	0.00366	0.052	CbGeAlD
Zoledronate—CA14—seminal vesicle—prostate cancer	0.00359	0.051	CbGeAlD
Zoledronate—FDPS—prostate gland—prostate cancer	0.00327	0.0465	CbGeAlD
Zoledronate—GGPS1—testis—prostate cancer	0.00313	0.0444	CbGeAlD
Zoledronate—FDPS—seminal vesicle—prostate cancer	0.00277	0.0393	CbGeAlD
Zoledronate—GGPS1—lymph node—prostate cancer	0.00227	0.0322	CbGeAlD
Zoledronate—CA12—renal system—prostate cancer	0.00226	0.032	CbGeAlD
Zoledronate—FDPS—renal system—prostate cancer	0.00223	0.0317	CbGeAlD
Zoledronate—FDPS—urethra—prostate cancer	0.00219	0.0311	CbGeAlD
Zoledronate—ABCC1—prostate gland—prostate cancer	0.0019	0.027	CbGeAlD
Zoledronate—CA2—prostate gland—prostate cancer	0.0017	0.0241	CbGeAlD
Zoledronate—FDPS—bone marrow—prostate cancer	0.00169	0.024	CbGeAlD
Zoledronate—ABCC1—seminal vesicle—prostate cancer	0.00161	0.0228	CbGeAlD
Zoledronate—FDPS—testis—prostate cancer	0.00144	0.0205	CbGeAlD
Zoledronate—CA2—seminal vesicle—prostate cancer	0.00144	0.0204	CbGeAlD
Zoledronate—ABCC1—urethra—prostate cancer	0.00127	0.0181	CbGeAlD
Zoledronate—CA2—epithelium—prostate cancer	0.00125	0.0177	CbGeAlD
Zoledronate—CA2—renal system—prostate cancer	0.00116	0.0164	CbGeAlD
Zoledronate—FDPS—lymph node—prostate cancer	0.00105	0.0148	CbGeAlD
Zoledronate—CA2—bone marrow—prostate cancer	0.000876	0.0124	CbGeAlD
Zoledronate—ABCC1—testis—prostate cancer	0.000837	0.0119	CbGeAlD
Zoledronate—CA2—testis—prostate cancer	0.000749	0.0106	CbGeAlD
Zoledronate—ABCC1—lymph node—prostate cancer	0.000607	0.00862	CbGeAlD
Zoledronate—CA2—lymph node—prostate cancer	0.000543	0.00771	CbGeAlD
Zoledronate—Risedronate—PTGS2—prostate cancer	0.000316	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—prostate cancer	0.000282	0.471	CrCbGaD
Zoledronate—Headache—Mitoxantrone—prostate cancer	4.94e-05	0.000165	CcSEcCtD
Zoledronate—Hypotension—Capecitabine—prostate cancer	4.93e-05	0.000165	CcSEcCtD
Zoledronate—Insomnia—Docetaxel—prostate cancer	4.93e-05	0.000165	CcSEcCtD
Zoledronate—Myalgia—Prednisone—prostate cancer	4.9e-05	0.000164	CcSEcCtD
Zoledronate—Arthralgia—Prednisone—prostate cancer	4.9e-05	0.000164	CcSEcCtD
Zoledronate—Paraesthesia—Docetaxel—prostate cancer	4.89e-05	0.000163	CcSEcCtD
Zoledronate—Anxiety—Prednisone—prostate cancer	4.88e-05	0.000163	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—prostate cancer	4.87e-05	0.000163	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.87e-05	0.000163	CcSEcCtD
Zoledronate—Dyspnoea—Docetaxel—prostate cancer	4.86e-05	0.000162	CcSEcCtD
Zoledronate—Somnolence—Docetaxel—prostate cancer	4.84e-05	0.000162	CcSEcCtD
Zoledronate—Discomfort—Prednisone—prostate cancer	4.84e-05	0.000162	CcSEcCtD
Zoledronate—Eye disorder—Epirubicin—prostate cancer	4.83e-05	0.000162	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—prostate cancer	4.83e-05	0.000161	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.8e-05	0.000161	CcSEcCtD
Zoledronate—Flushing—Epirubicin—prostate cancer	4.8e-05	0.00016	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—prostate cancer	4.8e-05	0.00016	CcSEcCtD
Zoledronate—Dyspepsia—Docetaxel—prostate cancer	4.79e-05	0.00016	CcSEcCtD
Zoledronate—Insomnia—Capecitabine—prostate cancer	4.77e-05	0.000159	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—prostate cancer	4.76e-05	0.000159	CcSEcCtD
Zoledronate—Paraesthesia—Capecitabine—prostate cancer	4.73e-05	0.000158	CcSEcCtD
Zoledronate—Decreased appetite—Docetaxel—prostate cancer	4.73e-05	0.000158	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—prostate cancer	4.72e-05	0.000158	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—prostate cancer	4.71e-05	0.000158	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Asthenia—Etoposide—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Dyspnoea—Capecitabine—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Anaphylactic shock—Prednisone—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Oedema—Prednisone—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—prostate cancer	4.7e-05	0.000157	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—prostate cancer	4.69e-05	0.000157	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—prostate cancer	4.69e-05	0.000157	CcSEcCtD
Zoledronate—Nausea—Mitoxantrone—prostate cancer	4.68e-05	0.000156	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—prostate cancer	4.67e-05	0.000156	CcSEcCtD
Zoledronate—Infection—Prednisone—prostate cancer	4.67e-05	0.000156	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—prostate cancer	4.66e-05	0.000156	CcSEcCtD
Zoledronate—Pain—Docetaxel—prostate cancer	4.66e-05	0.000156	CcSEcCtD
Zoledronate—Constipation—Docetaxel—prostate cancer	4.66e-05	0.000156	CcSEcCtD
Zoledronate—Dyspepsia—Capecitabine—prostate cancer	4.64e-05	0.000155	CcSEcCtD
Zoledronate—Chills—Epirubicin—prostate cancer	4.64e-05	0.000155	CcSEcCtD
Zoledronate—Pruritus—Etoposide—prostate cancer	4.64e-05	0.000155	CcSEcCtD
Zoledronate—Shock—Prednisone—prostate cancer	4.62e-05	0.000154	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—prostate cancer	4.62e-05	0.000154	CcSEcCtD
Zoledronate—Nervous system disorder—Prednisone—prostate cancer	4.61e-05	0.000154	CcSEcCtD
Zoledronate—Tachycardia—Prednisone—prostate cancer	4.58e-05	0.000153	CcSEcCtD
Zoledronate—Decreased appetite—Capecitabine—prostate cancer	4.58e-05	0.000153	CcSEcCtD
Zoledronate—Alopecia—Epirubicin—prostate cancer	4.57e-05	0.000153	CcSEcCtD
Zoledronate—Skin disorder—Prednisone—prostate cancer	4.56e-05	0.000153	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Capecitabine—prostate cancer	4.55e-05	0.000152	CcSEcCtD
Zoledronate—Fatigue—Capecitabine—prostate cancer	4.55e-05	0.000152	CcSEcCtD
Zoledronate—Hyperhidrosis—Prednisone—prostate cancer	4.54e-05	0.000152	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—prostate cancer	4.53e-05	0.000151	CcSEcCtD
Zoledronate—Pain—Capecitabine—prostate cancer	4.51e-05	0.000151	CcSEcCtD
Zoledronate—Constipation—Capecitabine—prostate cancer	4.51e-05	0.000151	CcSEcCtD
Zoledronate—Erythema—Epirubicin—prostate cancer	4.5e-05	0.00015	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—prostate cancer	4.5e-05	0.00015	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—prostate cancer	4.49e-05	0.00015	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—prostate cancer	4.48e-05	0.00015	CcSEcCtD
Zoledronate—Anorexia—Prednisone—prostate cancer	4.48e-05	0.00015	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—prostate cancer	4.47e-05	0.000149	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—prostate cancer	4.45e-05	0.000149	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—prostate cancer	4.44e-05	0.000148	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—prostate cancer	4.44e-05	0.000148	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—prostate cancer	4.41e-05	0.000147	CcSEcCtD
Zoledronate—Back pain—Epirubicin—prostate cancer	4.35e-05	0.000146	CcSEcCtD
Zoledronate—Feeling abnormal—Capecitabine—prostate cancer	4.35e-05	0.000145	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—prostate cancer	4.34e-05	0.000145	CcSEcCtD
Zoledronate—Dizziness—Etoposide—prostate cancer	4.33e-05	0.000145	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—prostate cancer	4.33e-05	0.000145	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—prostate cancer	4.32e-05	0.000144	CcSEcCtD
Zoledronate—Gastrointestinal pain—Capecitabine—prostate cancer	4.31e-05	0.000144	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—prostate cancer	4.31e-05	0.000144	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—prostate cancer	4.31e-05	0.000144	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—prostate cancer	4.31e-05	0.000144	CcSEcCtD
Zoledronate—Chills—Doxorubicin—prostate cancer	4.29e-05	0.000143	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Prednisone—prostate cancer	4.28e-05	0.000143	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—prostate cancer	4.27e-05	0.000143	CcSEcCtD
Zoledronate—Insomnia—Prednisone—prostate cancer	4.25e-05	0.000142	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—prostate cancer	4.24e-05	0.000142	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—prostate cancer	4.23e-05	0.000141	CcSEcCtD
Zoledronate—Paraesthesia—Prednisone—prostate cancer	4.22e-05	0.000141	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—prostate cancer	4.19e-05	0.00014	CcSEcCtD
Zoledronate—Urticaria—Capecitabine—prostate cancer	4.19e-05	0.00014	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—prostate cancer	4.18e-05	0.00014	CcSEcCtD
Zoledronate—Abdominal pain—Capecitabine—prostate cancer	4.17e-05	0.000139	CcSEcCtD
Zoledronate—Body temperature increased—Capecitabine—prostate cancer	4.17e-05	0.000139	CcSEcCtD
Zoledronate—Vomiting—Etoposide—prostate cancer	4.17e-05	0.000139	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—prostate cancer	4.16e-05	0.000139	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—prostate cancer	4.16e-05	0.000139	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—prostate cancer	4.16e-05	0.000139	CcSEcCtD
Zoledronate—Agitation—Epirubicin—prostate cancer	4.14e-05	0.000138	CcSEcCtD
Zoledronate—Dyspepsia—Prednisone—prostate cancer	4.13e-05	0.000138	CcSEcCtD
Zoledronate—Rash—Etoposide—prostate cancer	4.13e-05	0.000138	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—prostate cancer	4.13e-05	0.000138	CcSEcCtD
Zoledronate—Headache—Etoposide—prostate cancer	4.11e-05	0.000137	CcSEcCtD
Zoledronate—Decreased appetite—Prednisone—prostate cancer	4.08e-05	0.000136	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—prostate cancer	4.08e-05	0.000136	CcSEcCtD
Zoledronate—Malaise—Epirubicin—prostate cancer	4.06e-05	0.000136	CcSEcCtD
Zoledronate—Fatigue—Prednisone—prostate cancer	4.05e-05	0.000135	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—prostate cancer	4.04e-05	0.000135	CcSEcCtD
Zoledronate—Syncope—Epirubicin—prostate cancer	4.04e-05	0.000135	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—prostate cancer	4.03e-05	0.000135	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—prostate cancer	4.03e-05	0.000135	CcSEcCtD
Zoledronate—Constipation—Prednisone—prostate cancer	4.02e-05	0.000134	CcSEcCtD
Zoledronate—Hypersensitivity—Docetaxel—prostate cancer	4.01e-05	0.000134	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—prostate cancer	4e-05	0.000134	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—prostate cancer	3.98e-05	0.000133	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—prostate cancer	3.96e-05	0.000132	CcSEcCtD
Zoledronate—Cough—Epirubicin—prostate cancer	3.93e-05	0.000131	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—prostate cancer	3.93e-05	0.000131	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—prostate cancer	3.91e-05	0.000131	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—prostate cancer	3.9e-05	0.00013	CcSEcCtD
Zoledronate—Nausea—Etoposide—prostate cancer	3.89e-05	0.00013	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—prostate cancer	3.89e-05	0.00013	CcSEcCtD
Zoledronate—Hypersensitivity—Capecitabine—prostate cancer	3.88e-05	0.00013	CcSEcCtD
Zoledronate—Feeling abnormal—Prednisone—prostate cancer	3.87e-05	0.000129	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—prostate cancer	3.86e-05	0.000129	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—prostate cancer	3.85e-05	0.000129	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—prostate cancer	3.85e-05	0.000129	CcSEcCtD
Zoledronate—Gastrointestinal pain—Prednisone—prostate cancer	3.84e-05	0.000128	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—prostate cancer	3.83e-05	0.000128	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—prostate cancer	3.83e-05	0.000128	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—prostate cancer	3.83e-05	0.000128	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—prostate cancer	3.83e-05	0.000128	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—prostate cancer	3.82e-05	0.000128	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.81e-05	0.000127	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—prostate cancer	3.79e-05	0.000127	CcSEcCtD
Zoledronate—Asthenia—Capecitabine—prostate cancer	3.78e-05	0.000126	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—prostate cancer	3.76e-05	0.000126	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—prostate cancer	3.75e-05	0.000125	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—prostate cancer	3.74e-05	0.000125	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—prostate cancer	3.73e-05	0.000125	CcSEcCtD
Zoledronate—Urticaria—Prednisone—prostate cancer	3.73e-05	0.000125	CcSEcCtD
Zoledronate—Pruritus—Capecitabine—prostate cancer	3.73e-05	0.000125	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—prostate cancer	3.73e-05	0.000125	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—prostate cancer	3.73e-05	0.000125	CcSEcCtD
Zoledronate—Abdominal pain—Prednisone—prostate cancer	3.71e-05	0.000124	CcSEcCtD
Zoledronate—Body temperature increased—Prednisone—prostate cancer	3.71e-05	0.000124	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—prostate cancer	3.7e-05	0.000124	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—prostate cancer	3.68e-05	0.000123	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—prostate cancer	3.67e-05	0.000123	CcSEcCtD
Zoledronate—Oedema—Epirubicin—prostate cancer	3.67e-05	0.000123	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—prostate cancer	3.66e-05	0.000122	CcSEcCtD
Zoledronate—Infection—Epirubicin—prostate cancer	3.65e-05	0.000122	CcSEcCtD
Zoledronate—Cough—Doxorubicin—prostate cancer	3.63e-05	0.000121	CcSEcCtD
Zoledronate—Shock—Epirubicin—prostate cancer	3.61e-05	0.000121	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—prostate cancer	3.61e-05	0.000121	CcSEcCtD
Zoledronate—Diarrhoea—Capecitabine—prostate cancer	3.61e-05	0.000121	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—prostate cancer	3.6e-05	0.00012	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—prostate cancer	3.6e-05	0.00012	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—prostate cancer	3.6e-05	0.00012	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—prostate cancer	3.6e-05	0.00012	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—prostate cancer	3.59e-05	0.00012	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—prostate cancer	3.57e-05	0.000119	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—prostate cancer	3.55e-05	0.000119	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—prostate cancer	3.55e-05	0.000119	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—prostate cancer	3.55e-05	0.000119	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—prostate cancer	3.55e-05	0.000119	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—prostate cancer	3.53e-05	0.000118	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.52e-05	0.000118	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—prostate cancer	3.5e-05	0.000117	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—prostate cancer	3.5e-05	0.000117	CcSEcCtD
Zoledronate—Dizziness—Capecitabine—prostate cancer	3.49e-05	0.000117	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—prostate cancer	3.47e-05	0.000116	CcSEcCtD
Zoledronate—Vomiting—Docetaxel—prostate cancer	3.46e-05	0.000116	CcSEcCtD
Zoledronate—Hypersensitivity—Prednisone—prostate cancer	3.46e-05	0.000116	CcSEcCtD
Zoledronate—Rash—Docetaxel—prostate cancer	3.43e-05	0.000115	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—prostate cancer	3.43e-05	0.000115	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—prostate cancer	3.43e-05	0.000115	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—prostate cancer	3.43e-05	0.000115	CcSEcCtD
Zoledronate—Headache—Docetaxel—prostate cancer	3.41e-05	0.000114	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—prostate cancer	3.4e-05	0.000114	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—prostate cancer	3.4e-05	0.000114	CcSEcCtD
Zoledronate—Infection—Doxorubicin—prostate cancer	3.38e-05	0.000113	CcSEcCtD
Zoledronate—Asthenia—Prednisone—prostate cancer	3.37e-05	0.000113	CcSEcCtD
Zoledronate—Vomiting—Capecitabine—prostate cancer	3.35e-05	0.000112	CcSEcCtD
Zoledronate—ABCC1—Metabolism—MTAP—prostate cancer	3.35e-05	0.000292	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP7B1—prostate cancer	3.35e-05	0.000292	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.35e-05	0.000112	CcSEcCtD
Zoledronate—Shock—Doxorubicin—prostate cancer	3.34e-05	0.000112	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—prostate cancer	3.33e-05	0.000111	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—prostate cancer	3.33e-05	0.000111	CcSEcCtD
Zoledronate—Rash—Capecitabine—prostate cancer	3.32e-05	0.000111	CcSEcCtD
Zoledronate—Pruritus—Prednisone—prostate cancer	3.32e-05	0.000111	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—prostate cancer	3.32e-05	0.000111	CcSEcCtD
Zoledronate—Dermatitis—Capecitabine—prostate cancer	3.32e-05	0.000111	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—prostate cancer	3.32e-05	0.000111	CcSEcCtD
Zoledronate—ABCC1—Disease—TCN2—prostate cancer	3.31e-05	0.000289	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TYMS—prostate cancer	3.3e-05	0.000288	CbGpPWpGaD
Zoledronate—Headache—Capecitabine—prostate cancer	3.3e-05	0.00011	CcSEcCtD
Zoledronate—CA14—Metabolism—MTHFR—prostate cancer	3.3e-05	0.000288	CbGpPWpGaD
Zoledronate—Skin disorder—Doxorubicin—prostate cancer	3.3e-05	0.00011	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—prostate cancer	3.3e-05	0.00011	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—prostate cancer	3.29e-05	0.00011	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—prostate cancer	3.28e-05	0.000109	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	3.27e-05	0.000285	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GSTM1—prostate cancer	3.27e-05	0.000285	CbGpPWpGaD
Zoledronate—Somnolence—Epirubicin—prostate cancer	3.27e-05	0.000109	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SULT1E1—prostate cancer	3.26e-05	0.000285	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SRD5A1—prostate cancer	3.26e-05	0.000285	CbGpPWpGaD
Zoledronate—CA2—Metabolism—SLC5A5—prostate cancer	3.25e-05	0.000284	CbGpPWpGaD
Zoledronate—Anorexia—Doxorubicin—prostate cancer	3.24e-05	0.000108	CcSEcCtD
Zoledronate—CA14—Metabolism—PPARA—prostate cancer	3.24e-05	0.000282	CbGpPWpGaD
Zoledronate—Nausea—Docetaxel—prostate cancer	3.24e-05	0.000108	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—prostate cancer	3.23e-05	0.000108	CcSEcCtD
Zoledronate—Diarrhoea—Prednisone—prostate cancer	3.21e-05	0.000107	CcSEcCtD
Zoledronate—FDPS—Metabolism—LPL—prostate cancer	3.21e-05	0.000279	CbGpPWpGaD
Zoledronate—Decreased appetite—Epirubicin—prostate cancer	3.19e-05	0.000107	CcSEcCtD
Zoledronate—CA12—Metabolism—TYMS—prostate cancer	3.19e-05	0.000278	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2E1—prostate cancer	3.18e-05	0.000277	CbGpPWpGaD
Zoledronate—Hypotension—Doxorubicin—prostate cancer	3.18e-05	0.000106	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—prostate cancer	3.17e-05	0.000106	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	3.17e-05	0.000276	CbGpPWpGaD
Zoledronate—Fatigue—Epirubicin—prostate cancer	3.17e-05	0.000106	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTM1—prostate cancer	3.15e-05	0.000275	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NQO1—prostate cancer	3.14e-05	0.000274	CbGpPWpGaD
Zoledronate—Pain—Epirubicin—prostate cancer	3.14e-05	0.000105	CcSEcCtD
Zoledronate—Constipation—Epirubicin—prostate cancer	3.14e-05	0.000105	CcSEcCtD
Zoledronate—Nausea—Capecitabine—prostate cancer	3.13e-05	0.000105	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	3.12e-05	0.000272	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD17B3—prostate cancer	3.11e-05	0.000271	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACSL4—prostate cancer	3.11e-05	0.000271	CbGpPWpGaD
Zoledronate—Dizziness—Prednisone—prostate cancer	3.11e-05	0.000104	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.1e-05	0.000104	CcSEcCtD
Zoledronate—CA2—Metabolism—TH—prostate cancer	3.1e-05	0.00027	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1A1—prostate cancer	3.1e-05	0.00027	CbGpPWpGaD
Zoledronate—CA12—Metabolism—LPL—prostate cancer	3.09e-05	0.000269	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	3.08e-05	0.000268	CbGpPWpGaD
Zoledronate—Insomnia—Doxorubicin—prostate cancer	3.07e-05	0.000103	CcSEcCtD
Zoledronate—FDPS—Metabolism—ERCC2—prostate cancer	3.07e-05	0.000268	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP3A4—prostate cancer	3.06e-05	0.000267	CbGpPWpGaD
Zoledronate—Paraesthesia—Doxorubicin—prostate cancer	3.05e-05	0.000102	CcSEcCtD
Zoledronate—CA14—Metabolism—CAV1—prostate cancer	3.05e-05	0.000266	CbGpPWpGaD
Zoledronate—Dyspnoea—Doxorubicin—prostate cancer	3.03e-05	0.000101	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—prostate cancer	3.03e-05	0.000101	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—prostate cancer	3.02e-05	0.000101	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP1B1—prostate cancer	3.01e-05	0.000263	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Epirubicin—prostate cancer	3e-05	0.0001	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—prostate cancer	2.99e-05	0.0001	CcSEcCtD
Zoledronate—Vomiting—Prednisone—prostate cancer	2.99e-05	9.98e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PHGDH—prostate cancer	2.99e-05	0.00026	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UMPS—prostate cancer	2.99e-05	0.00026	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ARG2—prostate cancer	2.99e-05	0.00026	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—prostate cancer	2.99e-05	0.00026	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.97e-05	0.000259	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.97e-05	0.000259	CbGpPWpGaD
Zoledronate—Rash—Prednisone—prostate cancer	2.96e-05	9.9e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—ERCC2—prostate cancer	2.96e-05	0.000258	CbGpPWpGaD
Zoledronate—Dermatitis—Prednisone—prostate cancer	2.96e-05	9.89e-05	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—prostate cancer	2.95e-05	9.88e-05	CcSEcCtD
Zoledronate—Headache—Prednisone—prostate cancer	2.94e-05	9.84e-05	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.93e-05	9.81e-05	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—prostate cancer	2.93e-05	9.8e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—LDHB—prostate cancer	2.93e-05	0.000255	CbGpPWpGaD
Zoledronate—Urticaria—Epirubicin—prostate cancer	2.92e-05	9.76e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—GGT1—prostate cancer	2.92e-05	0.000254	CbGpPWpGaD
Zoledronate—Pain—Doxorubicin—prostate cancer	2.91e-05	9.72e-05	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—prostate cancer	2.91e-05	9.72e-05	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—prostate cancer	2.9e-05	9.71e-05	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—prostate cancer	2.9e-05	9.71e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—MTHFR—prostate cancer	2.89e-05	0.000252	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP3A5—prostate cancer	2.87e-05	0.000251	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOA1—prostate cancer	2.87e-05	0.00025	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP19A1—prostate cancer	2.83e-05	0.000247	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PPARA—prostate cancer	2.83e-05	0.000247	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RXRA—prostate cancer	2.82e-05	0.000246	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GSTO1—prostate cancer	2.82e-05	0.000246	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—prostate cancer	2.8e-05	9.36e-05	CcSEcCtD
Zoledronate—Nausea—Prednisone—prostate cancer	2.79e-05	9.33e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—MTHFR—prostate cancer	2.78e-05	0.000243	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Doxorubicin—prostate cancer	2.78e-05	9.29e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PDHA1—prostate cancer	2.78e-05	0.000242	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA3—prostate cancer	2.78e-05	0.000242	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TCN2—prostate cancer	2.78e-05	0.000242	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UCP3—prostate cancer	2.78e-05	0.000242	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—prostate cancer	2.77e-05	0.000242	CbGpPWpGaD
Zoledronate—CA2—Metabolism—RXRA—prostate cancer	2.73e-05	0.000238	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PPARA—prostate cancer	2.73e-05	0.000238	CbGpPWpGaD
Zoledronate—Hypersensitivity—Epirubicin—prostate cancer	2.71e-05	9.05e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—LRP2—prostate cancer	2.7e-05	0.000235	CbGpPWpGaD
Zoledronate—Urticaria—Doxorubicin—prostate cancer	2.7e-05	9.03e-05	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—prostate cancer	2.69e-05	8.98e-05	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—prostate cancer	2.69e-05	8.98e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—CAV1—prostate cancer	2.66e-05	0.000232	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EIF2AK2—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL10—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Disease—P4HB—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC22A3—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD3B1—prostate cancer	2.65e-05	0.000231	CbGpPWpGaD
Zoledronate—Asthenia—Epirubicin—prostate cancer	2.64e-05	8.81e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—COMT—prostate cancer	2.63e-05	0.000229	CbGpPWpGaD
Zoledronate—CA14—Metabolism—INS—prostate cancer	2.63e-05	0.000229	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—prostate cancer	2.62e-05	0.000228	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIST1H2BG—prostate cancer	2.6e-05	0.000227	CbGpPWpGaD
Zoledronate—Pruritus—Epirubicin—prostate cancer	2.6e-05	8.69e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—ITPR1—prostate cancer	2.58e-05	0.000225	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CREBBP—prostate cancer	2.57e-05	0.000224	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.57e-05	0.000224	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAV1—prostate cancer	2.57e-05	0.000224	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.54e-05	0.000222	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TBXAS1—prostate cancer	2.54e-05	0.000221	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA4—prostate cancer	2.54e-05	0.000221	CbGpPWpGaD
Zoledronate—Diarrhoea—Epirubicin—prostate cancer	2.51e-05	8.4e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—HIST1H4H—prostate cancer	2.51e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NPPA—prostate cancer	2.51e-05	0.000219	CbGpPWpGaD
Zoledronate—Hypersensitivity—Doxorubicin—prostate cancer	2.5e-05	8.37e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.48e-05	0.000216	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA2—prostate cancer	2.47e-05	0.000216	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG5—prostate cancer	2.44e-05	0.000213	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SULT1A1—prostate cancer	2.44e-05	0.000213	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—prostate cancer	2.44e-05	0.000213	CbGpPWpGaD
Zoledronate—Asthenia—Doxorubicin—prostate cancer	2.44e-05	8.15e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—TYMS—prostate cancer	2.44e-05	0.000212	CbGpPWpGaD
Zoledronate—Dizziness—Epirubicin—prostate cancer	2.43e-05	8.12e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CG—prostate cancer	2.43e-05	0.000211	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—prostate cancer	2.41e-05	0.00021	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—prostate cancer	2.4e-05	8.04e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTA1—prostate cancer	2.39e-05	0.000208	CbGpPWpGaD
Zoledronate—CA2—Metabolism—LPL—prostate cancer	2.36e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSD3B2—prostate cancer	2.36e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTO1—prostate cancer	2.36e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAT2—prostate cancer	2.36e-05	0.000206	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—prostate cancer	2.34e-05	0.000204	CbGpPWpGaD
Zoledronate—Vomiting—Epirubicin—prostate cancer	2.34e-05	7.81e-05	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—prostate cancer	2.33e-05	7.77e-05	CcSEcCtD
Zoledronate—Rash—Epirubicin—prostate cancer	2.32e-05	7.74e-05	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—prostate cancer	2.31e-05	7.74e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—NOS3—prostate cancer	2.3e-05	0.000201	CbGpPWpGaD
Zoledronate—Headache—Epirubicin—prostate cancer	2.3e-05	7.69e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—INS—prostate cancer	2.3e-05	0.0002	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1A1—prostate cancer	2.28e-05	0.000199	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	2.27e-05	0.000198	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ERCC2—prostate cancer	2.26e-05	0.000197	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LRP2—prostate cancer	2.26e-05	0.000197	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2C18—prostate cancer	2.26e-05	0.000197	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLCB2—prostate cancer	2.26e-05	0.000197	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CREBBP—prostate cancer	2.25e-05	0.000196	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—prostate cancer	2.25e-05	7.51e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—P4HB—prostate cancer	2.22e-05	0.000193	CbGpPWpGaD
Zoledronate—CA12—Metabolism—INS—prostate cancer	2.21e-05	0.000193	CbGpPWpGaD
Zoledronate—Nausea—Epirubicin—prostate cancer	2.18e-05	7.29e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—CREBBP—prostate cancer	2.17e-05	0.000189	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—prostate cancer	2.17e-05	0.000189	CbGpPWpGaD
Zoledronate—Vomiting—Doxorubicin—prostate cancer	2.16e-05	7.22e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SLC22A1—prostate cancer	2.16e-05	0.000188	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.16e-05	0.000188	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—prostate cancer	2.14e-05	7.16e-05	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—prostate cancer	2.14e-05	7.16e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—B2M—prostate cancer	2.14e-05	0.000186	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFBR1—prostate cancer	2.14e-05	0.000186	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.13e-05	0.000186	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—prostate cancer	2.13e-05	0.000186	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—prostate cancer	2.13e-05	7.12e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—MTHFR—prostate cancer	2.13e-05	0.000185	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—prostate cancer	2.13e-05	0.000185	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—prostate cancer	2.11e-05	0.000184	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SULT2A1—prostate cancer	2.1e-05	0.000183	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKR1C3—prostate cancer	2.1e-05	0.000183	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS19—prostate cancer	2.1e-05	0.000183	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKACB—prostate cancer	2.09e-05	0.000182	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PPARA—prostate cancer	2.09e-05	0.000182	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MED12—prostate cancer	2.07e-05	0.00018	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—prostate cancer	2.06e-05	0.000179	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNG5—prostate cancer	2.05e-05	0.000179	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPP3CA—prostate cancer	2.04e-05	0.000178	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—prostate cancer	2.02e-05	6.75e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—NOS3—prostate cancer	2.01e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA3—prostate cancer	1.98e-05	0.000172	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCZ—prostate cancer	1.97e-05	0.000172	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—prostate cancer	1.96e-05	0.000171	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.94e-05	0.000169	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—prostate cancer	1.94e-05	0.000169	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALR—prostate cancer	1.94e-05	0.000169	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PARP1—prostate cancer	1.9e-05	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR4—prostate cancer	1.9e-05	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HPGDS—prostate cancer	1.89e-05	0.000164	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALCA—prostate cancer	1.88e-05	0.000164	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2C19—prostate cancer	1.87e-05	0.000163	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—prostate cancer	1.86e-05	0.000162	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—prostate cancer	1.84e-05	0.00016	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTEN—prostate cancer	1.84e-05	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACHE—prostate cancer	1.83e-05	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—prostate cancer	1.83e-05	0.00016	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2A6—prostate cancer	1.81e-05	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HSPA1A—prostate cancer	1.8e-05	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.8e-05	0.000157	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—prostate cancer	1.79e-05	0.000156	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—prostate cancer	1.79e-05	0.000156	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—prostate cancer	1.78e-05	0.000155	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C3—prostate cancer	1.76e-05	0.000153	CbGpPWpGaD
Zoledronate—CA14—Metabolism—EP300—prostate cancer	1.75e-05	0.000153	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PRKACB—prostate cancer	1.75e-05	0.000153	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP17A1—prostate cancer	1.73e-05	0.000151	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CASP9—prostate cancer	1.73e-05	0.000151	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.71e-05	0.000149	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.71e-05	0.000149	CbGpPWpGaD
Zoledronate—CA2—Metabolism—INS—prostate cancer	1.69e-05	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRKCQ—prostate cancer	1.68e-05	0.000146	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CREBBP—prostate cancer	1.66e-05	0.000144	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA2—prostate cancer	1.65e-05	0.000144	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—prostate cancer	1.61e-05	0.00014	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF10—prostate cancer	1.59e-05	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A5—prostate cancer	1.57e-05	0.000137	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—prostate cancer	1.57e-05	0.000137	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—prostate cancer	1.55e-05	0.000135	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2E1—prostate cancer	1.54e-05	0.000134	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—EP300—prostate cancer	1.53e-05	0.000133	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NQO1—prostate cancer	1.52e-05	0.000133	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFBR2—prostate cancer	1.51e-05	0.000132	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TH—prostate cancer	1.5e-05	0.000131	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ITPR1—prostate cancer	1.49e-05	0.00013	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.49e-05	0.00013	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP3A4—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Zoledronate—CA12—Metabolism—EP300—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.48e-05	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1B1—prostate cancer	1.46e-05	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GGT1—prostate cancer	1.41e-05	0.000123	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA1—prostate cancer	1.39e-05	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP19A1—prostate cancer	1.37e-05	0.000119	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—prostate cancer	1.37e-05	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Disease—LPL—prostate cancer	1.37e-05	0.000119	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—prostate cancer	1.36e-05	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFRB—prostate cancer	1.35e-05	0.000118	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RXRA—prostate cancer	1.32e-05	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERCC2—prostate cancer	1.31e-05	0.000114	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—prostate cancer	1.3e-05	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.29e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB3—prostate cancer	1.28e-05	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR2—prostate cancer	1.28e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—COMT—prostate cancer	1.27e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—prostate cancer	1.27e-05	0.000111	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ITPR1—prostate cancer	1.25e-05	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—prostate cancer	1.23e-05	0.000107	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.23e-05	0.000107	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—prostate cancer	1.23e-05	0.000107	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—prostate cancer	1.18e-05	0.000103	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMS—prostate cancer	1.18e-05	0.000103	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—prostate cancer	1.17e-05	0.000102	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—prostate cancer	1.17e-05	0.000102	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LPL—prostate cancer	1.14e-05	9.97e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—prostate cancer	1.13e-05	9.89e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—prostate cancer	1.13e-05	9.87e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—EP300—prostate cancer	1.13e-05	9.84e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—prostate cancer	1.1e-05	9.63e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ERCC2—prostate cancer	1.1e-05	9.55e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—prostate cancer	1.09e-05	9.52e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BAD—prostate cancer	1.07e-05	9.3e-05	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—prostate cancer	1.06e-05	9.23e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—prostate cancer	1.03e-05	9.01e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—prostate cancer	1.03e-05	8.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS1—prostate cancer	1.02e-05	8.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGF—prostate cancer	1.02e-05	8.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPARA—prostate cancer	1.01e-05	8.81e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GSK3B—prostate cancer	9.92e-06	8.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—INS—prostate cancer	9.78e-06	8.53e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CREBBP—prostate cancer	9.58e-06	8.35e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—prostate cancer	9.5e-06	8.28e-05	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—prostate cancer	9.25e-06	8.07e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K1—prostate cancer	9.15e-06	7.97e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—prostate cancer	9.09e-06	7.92e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.08e-06	7.91e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—prostate cancer	8.99e-06	7.83e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—prostate cancer	8.92e-06	7.78e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF2—prostate cancer	8.7e-06	7.58e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—prostate cancer	8.65e-06	7.54e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—prostate cancer	8.58e-06	7.48e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—prostate cancer	8.35e-06	7.28e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JAK2—prostate cancer	8.34e-06	7.27e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—INS—prostate cancer	8.19e-06	7.14e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—prostate cancer	8.14e-06	7.09e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CREBBP—prostate cancer	8.02e-06	6.99e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—prostate cancer	8.02e-06	6.99e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—prostate cancer	7.92e-06	6.9e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—prostate cancer	7.85e-06	6.84e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—prostate cancer	7.61e-06	6.63e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—prostate cancer	7.43e-06	6.48e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—prostate cancer	7.18e-06	6.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—prostate cancer	7.02e-06	6.12e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—prostate cancer	6.86e-06	5.98e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—prostate cancer	6.84e-06	5.96e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—prostate cancer	6.82e-06	5.95e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—prostate cancer	6.63e-06	5.78e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—prostate cancer	6.57e-06	5.73e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EP300—prostate cancer	6.53e-06	5.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—prostate cancer	6.35e-06	5.53e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—prostate cancer	6.12e-06	5.33e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—prostate cancer	5.73e-06	5e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—prostate cancer	5.69e-06	4.96e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—prostate cancer	5.67e-06	4.94e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—prostate cancer	5.56e-06	4.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—EP300—prostate cancer	5.47e-06	4.76e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—prostate cancer	5.25e-06	4.58e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—prostate cancer	4.83e-06	4.21e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—prostate cancer	4.27e-06	3.73e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—prostate cancer	4.04e-06	3.52e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—prostate cancer	3.94e-06	3.44e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—prostate cancer	3.3e-06	2.88e-05	CbGpPWpGaD
